These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15846730)

  • 1. Rivastigmine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004744. PubMed ID: 15846730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors for Parkinson's disease dementia.
    Maidment I; Fox C; Boustani M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J ; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (4):CD001191. PubMed ID: 11034705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivastigmine for Alzheimer's disease.
    Birks JS; Chong LY; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD001191. PubMed ID: 26393402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for dementia with Lewy bodies.
    Wild R; Pettit T; Burns A
    Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivastigmine for subcortical vascular dementia.
    Román GC
    Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinpocetine for cognitive impairment and dementia.
    Szatmari SZ; Whitehouse PJ
    Cochrane Database Syst Rev; 2003; 2003(1):CD003119. PubMed ID: 12535455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment for memory disorder in multiple sclerosis.
    He D; Zhou H; Guo D; Hao Z; Wu B
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008876. PubMed ID: 21975787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans J
    Cochrane Database Syst Rev; 2000; (2):CD001011. PubMed ID: 10796585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.